Ignite Creation Date:
2025-12-24 @ 11:19 PM
Ignite Modification Date:
2025-12-25 @ 9:01 PM
Study NCT ID:
NCT01822756
Status:
TERMINATED
Last Update Posted:
2018-02-12
First Post:
2013-03-28
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
An Open-Label Study of Ruxolitinib Given With Chemotherapy in Patients With Advanced Solid Tumors
Sponsor:
Incyte Corporation
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-04
Start Date Type:
None
Primary Completion Date:
2015-09
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-08
Completion Date Type:
ACTUAL
First Submit Date:
2013-03-28
First Submit QC Date:
None
Study First Post Date:
2013-04-02
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2016-09-20
Results First Submit QC Date:
None
Results First Post Date:
2017-04-13
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-01-15
Last Update Post Date:
2018-02-12
Last Update Post Date Type:
ACTUAL